Salvianolic acid a attenuates limb ischemia/reperfusion injury in skeletal muscle of rats. 2018

Yijia Xiang, and Shiyong Ye, and Changhong Cai, and Junchong Chen, and Xuyong Zhao, and Ning Zhu, and Chunlai Zeng
Department of Cardiology, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang 323000, China.

Ischemia and reperfusion(I/R) injury can cause complications in applying blood flow treatment for atherosclerosis occlusion syndrome. Platelet activation and inflammatory reaction play a role in the procession of I/R injury. This study was designed to investigate the effects of Salvianolic Acid A(SAA) on limb I/R injury via inhibition of platelet activation and inflammatory reaction. Rats were divided into sham, I/R, I/R+SAA-Low (5mg/kg) and I/R+SAA-high (10mg/kg) groups with a procession of 6h for ischemia and 24h for reperfusion in the femoral artery of the right hind limb, with the exception of the sham group. SAA was injected into the right jugular vein before reperfusion. Reperfusion recovery was monitored by Laser Doppler. HE staining, electron microscopy examination and MDA were used to evaluate the I/R injury. ELISA, Western Blot and RT-PCR were used to measure the levels of P-selectin, IL-8(KC), ICAM-1, TNF-α, IL-1β, CK and NF-κB in plasma or tissues. Pretreatment with SAA attenuated skeletal muscle edema and mitochondria changes, and decreased the levels of MDA and CK. Meanwhile, there was significant reduction of P-selectin, KC, ICAM-1, TNF-α, IL-1β and NF-κB with treatment of SAA. Pretreatment with SAA may attenuate the I/R injury in the skeletal muscle tissues of rats via inhibition of platelet activation and inflammatory reaction.

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008297 Male Males
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002109 Caffeic Acids A class of phenolic acids related to chlorogenic acid, p-coumaric acid, vanillic acid, etc., which are found in plant tissues. It is involved in plant growth regulation. Acids, Caffeic
D006614 Hindlimb Either of two extremities of four-footed non-primate land animals. It usually consists of a FEMUR; TIBIA; and FIBULA; tarsals; METATARSALS; and TOES. (From Storer et al., General Zoology, 6th ed, p73) Hindlimbs
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015427 Reperfusion Injury Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. Ischemia-Reperfusion Injury,Injury, Ischemia-Reperfusion,Injury, Reperfusion,Reperfusion Damage,Damage, Reperfusion,Injury, Ischemia Reperfusion,Ischemia Reperfusion Injury,Ischemia-Reperfusion Injuries,Reperfusion Damages,Reperfusion Injuries
D017207 Rats, Sprague-Dawley A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company. Holtzman Rat,Rats, Holtzman,Sprague-Dawley Rat,Rats, Sprague Dawley,Holtzman Rats,Rat, Holtzman,Rat, Sprague-Dawley,Sprague Dawley Rat,Sprague Dawley Rats,Sprague-Dawley Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D054328 Proton Pump Inhibitors Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. Proton Pump Inhibitor,Inhibitor, Proton Pump,Inhibitors, Proton Pump,Pump Inhibitor, Proton

Related Publications

Yijia Xiang, and Shiyong Ye, and Changhong Cai, and Junchong Chen, and Xuyong Zhao, and Ning Zhu, and Chunlai Zeng
January 2016, African journal of traditional, complementary, and alternative medicines : AJTCAM,
Yijia Xiang, and Shiyong Ye, and Changhong Cai, and Junchong Chen, and Xuyong Zhao, and Ning Zhu, and Chunlai Zeng
February 2006, Acta orthopaedica,
Yijia Xiang, and Shiyong Ye, and Changhong Cai, and Junchong Chen, and Xuyong Zhao, and Ning Zhu, and Chunlai Zeng
May 1998, The American journal of physiology,
Yijia Xiang, and Shiyong Ye, and Changhong Cai, and Junchong Chen, and Xuyong Zhao, and Ning Zhu, and Chunlai Zeng
April 2015, The Journal of surgical research,
Yijia Xiang, and Shiyong Ye, and Changhong Cai, and Junchong Chen, and Xuyong Zhao, and Ning Zhu, and Chunlai Zeng
February 2016, International immunopharmacology,
Yijia Xiang, and Shiyong Ye, and Changhong Cai, and Junchong Chen, and Xuyong Zhao, and Ning Zhu, and Chunlai Zeng
January 2019, Oxidative medicine and cellular longevity,
Yijia Xiang, and Shiyong Ye, and Changhong Cai, and Junchong Chen, and Xuyong Zhao, and Ning Zhu, and Chunlai Zeng
January 2021, Frontiers in pharmacology,
Yijia Xiang, and Shiyong Ye, and Changhong Cai, and Junchong Chen, and Xuyong Zhao, and Ning Zhu, and Chunlai Zeng
December 2020, Journal of cellular physiology,
Yijia Xiang, and Shiyong Ye, and Changhong Cai, and Junchong Chen, and Xuyong Zhao, and Ning Zhu, and Chunlai Zeng
February 2020, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
Yijia Xiang, and Shiyong Ye, and Changhong Cai, and Junchong Chen, and Xuyong Zhao, and Ning Zhu, and Chunlai Zeng
January 2022, Oxidative medicine and cellular longevity,
Copied contents to your clipboard!